These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10360096)

  • 1. Potential for treatment with thrombolysis in an Irish stroke unit.
    Collins DR; O'Neill D; McCormack PM
    Ir Med J; 1999; 92(1):236-8. PubMed ID: 10360096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of lesion side on acute stroke treatment.
    Di Legge S; Fang J; Saposnik G; Hachinski V
    Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Lundstadsveen MT; Thomassen L
    J Stroke Cerebrovasc Dis; 2008; 17(3):141-6. PubMed ID: 18436155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a stroke thrombolysis service within a tertiary neurosciences centre in the United Kingdom.
    McCormick MT; Reeves I; Baird T; Bone I; Muir KW
    QJM; 2008 Apr; 101(4):291-8. PubMed ID: 18256038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
    Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision support and the appropriate use of fibrinolysis in myocardial infarction.
    Kellett J
    Eff Clin Pract; 2001; 4(1):1-9. PubMed ID: 11234180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.